ArticleBlood2012

Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.

Bing Z Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.